|Day Low/High||14.17 / 14.54|
|52 Wk Low/High||8.31 / 32.74|
What's next for Valeant Pharmaceuticals shares?
Jim Cramer says despite chaos in Washington, the market's not falling. Why? Because stocks aren't a referendum on the presidency.
Joe Papa, chairman and CEO of Valeant Pharmaceuticals International, talks to Jim Cramer about his company's turnaround.
Here's what you need to know now for Wed., Aug. 9.
The Laval, Quebec-based pharmaceutical company updated its revenue guidance and maintained its adjusted Ebitda outlook.
Here's what you need to know now for Tuesday, Aug. 8.
Amgen, Compugen and Foundation Medicine were among the biotech stock movers in premarket trading on July 26.
FibroGen, Depomed and Valeant were among the biotech stock movers in premarket trading on Aug. 8.
U.S. stock futures point to a lower open for Wall Street on Tuesday.
The focus remains on earnings while the season winds down.
The UN Security Council unanimously voted Saturday to sanction North Korea for ballistic missile tests, but currencies and futures barely budged.
As Ackman's fund, Pershing Square, pushing for control of the board at ADP, the company highlights that the fund has underperformed ADP in recent years.
Here's what you need to know now for Thursday, Aug. 3.
Ackman seeks to take five of ten seats on the human resources company's board. Here's what he really wants.
Valeant Pharmaceuticals will report second quarter earnings results next Tuesday, August 8.
The billionaire investor is known for taking big bets.
Jim Cramer says some sellers are making a big mistake by not giving top-notch CEOs the benefit of the doubt despite earnings upheaval.
Jim Cramer is bullish on Hertz Global Holdings, Honeywell, PetMed Express, and Allergan.
Stocks hold close to flat before a rush of earnings reports this week.
Here's what you need to know now.
Valeantacquired Obagi for $420 million but has sold the business for a fraction.
Stocks hold close to flat of a rush of earnings reports this week.
Stocks mostly higher ahead of a rush of earnings reports this week.
Stock futures higher ahead of a rush of earnings reports this week.